- Patent Title: Compositions and methods for the treatment of retinal degeneration
-
Application No.: US14380493Application Date: 2013-02-25
-
Publication No.: US09636377B2Publication Date: 2017-05-02
- Inventor: Vincent Marion , Anaïs Mockel , Hélène Dollfus
- Applicant: UNIVERSITE DE STRASBOURG
- Applicant Address: FR Strasbourg
- Assignee: UNIVERSITE DE STRASBOURG
- Current Assignee: UNIVERSITE DE STRASBOURG
- Current Assignee Address: FR Strasbourg
- Agency: Saliwanchik, Lloyd & Eisenschenk
- International Application: PCT/EP2013/053724 WO 20130225
- International Announcement: WO2013/124484 WO 20130829
- Main IPC: A61K38/07
- IPC: A61K38/07 ; A61K31/19 ; A61K45/00 ; A61K31/155 ; A61K45/06 ; A61K38/22 ; A61K38/55
Abstract:
The present invention relates to a pharmaceutical composition comprising an inhibitor of eIF2α, a compound increasing the expression and/or activity of protein BiP and/or an inhibitor of Caspase-12, preferably an inhibitor of eIF2α and a compound increasing the expression and/or activity of protein BiP. The present invention also relates to pharmaceutical compositions and methods for treating retinal degeneration related to ciliary dysfunction.
Public/Granted literature
- US20150038432A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF RETINAL DEGENERATION Public/Granted day:2015-02-05
Information query
IPC分类:
